Sweden-based Immunovia is preparing to launch its first diagnostic — a liquid biopsy test for pancreatic cancer — in 2018.
The subsidiary, called ExcitePCR, will own and complete development of the company's Firefly Dx real-time PCR breadboard prototype pathogen detection system.
The subsidiary is being formed in support of Biocartis' recent US distribution deal with Thermo Fisher Scientific.
Ardigen will form a new business unit to conduct biological and clinical data analysis in genomics, transcriptomics, proteomics, metabolomics, and immunomics.
The firm says a direct presence in China will help it expand its reach into a market where it has already sold 60 MassArray systems.
The Geneva-based subsidiary was opened to respond to increasing European demand for the firm's LinkSeq tissue typing test.
The South Korean molecular diagnostics firm plans to grow its global market presence and pursue FDA approval for its products from Seegene Technologies, its new base in California.
NEW YORK (GenomeWeb News) – Analytik Jena today announced that its French subsidiary has begun operations.
NEW YORK (GenomeWeb News) – UK-based point of care diagnostics firm EKF Diagnostics Holdings today announced it has formed a new firm to focus on molecular and companion diagnostics.
NEW YORK (GenomeWeb News) – A personalized molecular medicine company offering physicians access to clinically actionable genetic tests has been launched.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.